uniQure Gene Therapy Leadership January 2024

Loading viewer...

investor_presentation

Format: PDF investor_presentation

uniQure presents corporate strategy and pipeline progress in gene therapy, focusing on AMT-130 development for Huntington's disease treatment. The presentation outlines clinical trial data, biomarker utility for target engagement, and regulatory pathway advancement in the U.S. and Europe.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

Similar investor_presentations from other companies

Browse all →

Himalaya Shipping Investor Presentation March 2023

investor_presentation

23 Pages

Himalaya Shipping Ltd.

Aston Minerals ASO June 2023 Investor Presentation

investor_presentation